Zsírmáj (MASLD/MASH): vizsgálatok itt: Ausztrália

In Ausztrália 10 Also abroad 367

10 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

1. fázisTaking people
A Study of INI-822 in Healthy Volunteers and Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) or Presumed MASH
Where
Bedford Park, Birtinya, Box Hill, Campbelltown, Camperdown, Fitzroy, Mandurah, Newcastle, Osborne Park, Saint Leonards, Westmead, Woolloongabba
Életkor
18 év to 70 év
People
168
Run by
Inipharm Australia Pty Ltd
See details and how to joinNCT05945537
3. fázisTaking people
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Where
Adelaide, Broadmeadow, Caulfield South, Coffs Harbour, Epping, Frankston, Heidelberg, Kogarah, Liverpool, Melbourne, Murdoch, Nedlands, Penrith, Perth, Westmead
Életkor
18 év to 80 év
People
1650 worldwide
Run by
Akero Therapeutics, Inc
See details and how to joinNCT06215716
3. fázisTaking people
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Where
Birtinya, Clayton, Concord, Heidelberg, Kingswood, Liverpool, Parkville, Perth, Westmead
Életkor
18 év and over
People
1800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06632444 · EU 2024-513739-25-00
3. fázisTaking people
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Where
Clayton, Concord, Heidelberg, Kingswood, Liverpool, Parkville, Perth, Westmead
Életkor
18 év and over
People
1590 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT06632457 · EU 2024-513741-36-00
3. fázisTaking people
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Where
Adelaide, Bedford Park, Brisbane, Clayton, Fitzroy, Heidelberg, Herston, Murdoch, Perth, South Brisbane
Életkor
18 év to 80 év
People
1350 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06318169 · EU 2023-509912-27-00
3. fázisTaking people
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Where
Adelaide, Fitzroy, Greenslopes, Heidelberg, Herston, Murdoch, Perth, South Brisbane
Életkor
18 év to 75 év
People
1800 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06419374 · EU 2023-510395-31-00
3. fázisTaking people
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Where
Adelaide, Box Hill, Broadmeadow, Clayton, Coffs Harbour, Epping, Heidelberg, Herston, Kingswood, Liverpool, Melbourne, Murdoch, Nedlands, Perth, Westmead
Életkor
18 év to 80 év
People
2150 worldwide
Run by
Akero Therapeutics, Inc
See details and how to joinNCT06528314
3. fázisTaking people
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Where
Adelaide, Box Hill, Brisbane, Broadmeadow, Geelong, Heidelberg, Ipswich, Murdoch, Osborne Park, Parkville, Southport, Westmead
Életkor
18 év and over
People
4500 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07165028 · EU 2025-522674-36-00
3. fázisTaking people
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Where
Woolloongabba
Életkor
18 év to 75 év
People
1250 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07221188 · EU 2025-523674-16-00
3. fázisTaking people
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Where
Broadmeadow, Heidelberg
Életkor
18 év to 75 év
People
1200 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07221227